Public Policy Reviews

hero-bg

Overview

The European Haemophilia Consortium’s periodic review of the European public policy is entirely developed by the EHC to inform its National Member Organisations (NMOs) about the rapidly changing landscape of health policy and legislative developments which have a direct impact on the bleeding disorders community.          

Initially sent to the EHC NMOs in the form of a quarterly policy review, this informational product has recently been transformed into a periodic report and will be available to readers on our website.

We hope that the information provided herein is useful and we remain available for any questions.

Please consult the latest reviews below.

Public Policy Reviews

2022


Year of 2022

The current edition covers legislative initiatives of 2022.
It is designed to provide the readers with a retrospective overview.
All initiatives will be further monitored by the EHC.

2023


January – August 2023

The current edition covers legislative initiatives of the first half of 2023.
It is designed to provide the readers with a retrospective overview.
All initiatives will be further monitored by the EHC.

2024

September 2023 – January 2024

The current edition covers legislative initiatives of the second half of 2023.
It is designed to provide the readers with a retrospective overview.
All initiatives will be further monitored by the EHC.